In this blog, I review six randomised, controlled trials comparing N-Acetylcysteine (NAC) versus placebo for the treatment of OCD. NAC is a glutamate regulator and has good tolerability. Four trials tested it in adults, and two tested it in children.
In this blog I discuss a recent publication (Davis et al, 2020) which looked at a novel treatment for depression: Psilocybin. I review the study, look at the outcomes, and consider what the implications might be for treatment.
Most of us will consume caffeine in some form, but what if it could reduce symptoms of OCD? A recent study (Naftalovich et al, 2020) explored whether caffeine could help inhibition - which includes the ability to suppress or change intrusive thoughts. Here, we look at this study to see whether caffeine might be therapeutically helpful.